XML 36 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
REVENUE
12 Months Ended
Dec. 31, 2018
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Revenue Recognition

Revenues are recognized when control of the promised goods is transferred to customers, in an amount that reflects the consideration we expect to realize in exchange for those goods.

The following table presents revenues disaggregated by revenue source (in thousands). Sales and usage-based taxes are excluded from revenues.
 
 
2018
 
2017
 
2016
Product Sales
 
$
590,790

 
$
542,065

 
$
505,174

Co-manufacturing
 
41,348

 
41,658

 
39,396

Bill and Hold
 
4,612

 
4,094

 
3,061

Consignment
 
2,442

 
2,333

 
2,170

Product Sales Revenue
 
639,192

 
590,150

 
549,801

 
 
 
 
 
 
 
Royalty Revenue
 
4,487

 
4,640

 
3,403

 
 
 
 
 
 
 
Total
 
$
643,679

 
$
594,790

 
$
553,204


The following table presents revenues disaggregated by geography, based on the billing addresses of customers (in thousands):
 
 
2018
 
2017
 
2016
United States
 
$
482,691

 
$
460,599

 
$
420,821

Foreign Countries
 
160,988

 
134,191

 
132,383

Total
 
$
643,679

 
$
594,790

 
$
553,204



Product Sales Revenues

The Company’s primary operation is the manufacturing and sale of health and wellness ingredient products, in which the Company receives an order from a customer and fulfills that order. The Company’s product sales have four sub-streams of revenue: product sales, co-manufacturing, bill and hold, and consignment.

Under the co-manufacturing agreements, the Company is responsible for the manufacture of a finished good where the customer provides some or all of the raw materials.  The Company controls the manufacturing process and the ultimate end-product before it is shipped to the customer.  Based on these factors, the Company has determined that it is the principal in these agreements and therefore revenue is recognized in the gross amount of consideration the Company expects to be entitled for the goods provided.

Royalty Revenues

Royalty revenue consists of agreements with customers to use the Company’s intellectual property in exchange for a sales-based royalty. Royalty revenue is recorded as part of the Human Nutrition & Health segment.

Contract Liabilities

The Company records contract liabilities when cash payments are received or due in advance of performance, including amounts which are refundable.

The Company’s payment terms vary by the type and location of customers and the products offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, the Company requires payment before the products are delivered to the customer.

Practical Expedients and Exemptions

The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling and marketing expenses.

The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for products shipped.